Clinical Trial Update: Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating quetiapine for Borderline Personality Disorder has completed. No efficacy results are included in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED